What Your DNA Actually Tells You (And What It Doesn't)

There's a version of genetic testing that gets oversold constantly. The promise is simple and seductive: spit in a tube, send it off, and receive a complete picture of who you are and what diseases you'll get. That's not what genetic testing does. It's also not what it has to do to be genuinely useful.

The actual picture is more interesting than the hype, but it requires being honest about what the technology does well and where it runs out of steam.

What the test actually reads

A consumer genetic test doesn't sequence your entire genome. What most companies, including GeneLens, do is called genotyping. Your DNA contains roughly three billion base pairs. A genotyping array reads somewhere between 500,000 and 900,000 specific positions that researchers have identified as informative. That's less than 0.03% of your genome, but those positions were chosen because they carry the most signal for ancestry, health predispositions, and traits.

Full genome sequencing reads every base pair, but the interpretation challenge is enormous. Most variants discovered in a full sequence have no known function. Having more data doesn't automatically mean having more answers.

What the science genuinely supports

Ancestry composition is the most reliable output of consumer genetic testing. The underlying method - comparing your genetic variants against reference populations - is well-validated, and while the exact percentages shift depending on which reference panel a company uses, the broad geographic conclusions are solid. If the test says you have substantial East Asian ancestry, you do. The precision of "34.7% Korean" is an estimate; the directional finding is not.

Carrier status testing is also highly reliable. Whether you carry a variant associated with cystic fibrosis or spinal muscular atrophy is a relatively straightforward genetic question. The variants in question are known, the assay either detects them or it doesn't, and the clinical interpretation is well-established. This is one of the most medically meaningful things a consumer test can tell you, particularly if you're thinking about having children.

Pharmacogenomics, or how your body processes specific medications, is a third area where the genetics are relatively deterministic. Variants in genes like CYP2D6 and SLCO1B1 have a direct, well-documented effect on drug metabolism. Knowing you're a poor metabolizer for certain antidepressants or that you carry elevated statin-related muscle risk is genuinely actionable information.

Where the nuance lives

Health predisposition reports are where people most often misread what the test is saying. A polygenic risk score for type 2 diabetes, heart disease, or breast cancer is a statistical estimate based on hundreds or thousands of common genetic variants. It tells you something real about your relative risk compared to the general population. It does not tell you whether you will get the disease.

The reason matters: most common diseases arise from a combination of genetics, environment, and behavior. Your genome is one input. Someone with a high polygenic score for heart disease who exercises regularly, maintains a healthy weight, and doesn't smoke may have lower absolute risk than someone with a low score who does none of those things. Genetics sets probabilities, not outcomes.

Trait reports - sleep quality, athletic performance, nutrient metabolism - are the least predictively powerful. These involve many genes, and the environmental contribution is often larger than the genetic one. They're interesting, and some have modest research support, but you should hold them loosely.

What no test can tell you

Your genetic test won't tell you when you'll die, whether you'll develop Alzheimer's (though APOE4 status adds context), or how your life will turn out. It won't capture rare variants that weren't included in the genotyping array. It won't account for epigenetics - the way gene expression changes based on what you eat, how you sleep, or what you're exposed to.

It also won't replace a conversation with a doctor or genetic counselor when the findings are clinically significant. We say this not as a legal disclaimer, but because it's genuinely true. A positive BRCA2 finding is not something to interpret from a PDF alone. The result is one piece of information in a larger clinical picture.

The right way to think about it

A genetic test is a probabilistic tool, not a crystal ball. The best way to approach your results is with curiosity rather than anxiety. Use the carrier status findings to have informed conversations before major life decisions. Use the pharmacogenomics data when you're starting a new medication. Use the ancestry results to explore history, not to settle identity debates.

What the test can't do is as important to understand as what it can. Not because the limitations are reasons not to test, but because understanding them lets you use the results well.